ASX News Health Care Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these… Caroline Smith2 mins20 December 2024 11:05 (AEDT)